Enalaprilat inhibited in a dose-dependent manner the increases in stromal cell alkaline phosphatase activity and media PGE concentration that occurred in the control cultures; these effects were fully reversed by concurrent treatment with angiotensin II. The inhibition of stromal alkaline phosphatase activity was also reversed by PGE2; conversely, the ability of angiotensin II to reverse the effect of enalaprilat was lost in the presence of indomethacin. These studies provide evidence of a requirement for angiotensin II during the decidual cell reaction in rats and suggest that it acts, at least in part, through a PG-dependent mechanism.
Introduction
In species in which implantation of the blastocyst is invasive, the endometrium undergoes a response termed the decidual cell reaction, a response that can also be artificially induced by the application of various stimuli to the sensitized uterus (Psychoyos, 1973) . The processes accompanying decidualization (the differentiation of endometrial stromal cells into decidual cells) include a number of changes in the uterine vasculature. It is well established that an increase in endometrial vascular permeability precedes implantation and decidualization, and appears to be a prerequisite for these events (Psychoyos, 1973; Kennedy, 1986) . In addition, enlargement of uterine blood vessels and extensive neovascularization of the uterus occur after application of stimuli that induce decidualization (Lobel et al, 1965) , as does a rapid increase in uterine blood flow (Edwards & Milligan, 1987) . Prostaglandins (PGs), particularly those of the E series, have been implicated as key mediators of the increased endometrial vascular permeability and subsequent decidualization; it has also been suggested that the production of other vasoactive mediators, in addition to PGs, by the endometrium may be essential for some of these reactions to occur (Kennedy, 1980a) .
The octapeptide angiotensin II increases vascular permeability (Robertson & Khairallah, 1972) and is angiogenic (Fernandez et al, 1982; Fernandez et al, 1985) . There is substantial evidence for the local production of this peptide and for the presence of the enzymes for its synthesis, renin and angiotensin-converting enzyme, in the uteri of a number of species (Cushman & Cheung, 1971; Deboben et al, 1983; Naruse et al, 1985) , including rats. Specific and saturable angiotensin II binding has also been demonstrated in rat uterus (Lin & Goodfriend, 1970) .
Administered angiotensin II increases uterine blood flow in pregnant sheep (Bruce et al, 1981) and monkeys (Speroff et al, 1977) ; in the latter, this response is inhibited by indomethacin, a blocker of PG synthesis. Conversely, inhibition of angiotensin-converting enzyme reduces blood flow and PGE production in the uterus of pregnant rabbits (Ferris & Weir, 1983) . These results suggest indirectly that angiotensin II might also be involved in the increased uterine blood flow and PG concentration responses that occur during the decidual cell reaction.
The studies reported here investigated a role for angiotensin II in decidualization in rats by determining the effects of inhibition of endometrial angiotensin II synthesis on this reaction, on the assumption that if angiotensin II directly or indirectly mediates the endometrial vascular responses that occur during the decidual cell reaction, then inhibiting its synthesis would reduce the extent of decidualization. We studied the effects of intrauterine infusion of enalapril and enalaprilat, specific inhibitors of angiotensin-converting enzyme, on various aspects of the decidual cell reaction in ovariectomized, steroid-treated rats. Enalaprilat (MK 422 
, a noncompetitive, active-site-directed inhibitor of angiotensin-converting enzyme (Oparil, 1983) . Enalapril, when administered systemically, requires hepatic metabolism for biological activity; when administered intraluminally, an effect of enalaprilat but not of enalapril is expected.
An increase in alkaline phosphatase activity in the endometrial stroma is associated with decidualization (Lobel et al, 1965) and early pregnancy (Christie, 1966; Manning et al, 1969 ). This increase is maximal 24-72 h after the induction of decidualization and provides a good index of endometrial differentiation. Measurements of endometrial alkaline phosphatase activity, uterine weight, endometrial vascular permeability and uterine PG concentration were used to assess the effects of inhibition of angiotensin-converting enzyme on the decidual cell reaction. 
Materials and Methods

Animals
Treatments
Rats weighing 200-225 g were ovariectomized under ether anaesthesia and allowed at least 6 days to recover from surgery. To obtain rats sensitized for the decidual cell reaction, oestradiol and progesterone were given subcutaneously to the animals in the sequence described by Kennedy (1985) . For The empty pumps were incubated overnight at room temperature in 0-9% NaCl and were filled with the freshly prepared solutions just before being implanted into the animals. The technique for inserting the minipumps has been described by Kennedy & Lukash (1982) . One uterine horn of each animal was infused from the uterotubal end toward the cervical end with the contralateral noninfused horn serving as a control.
In vitro preparation: cell cultures Between 08:00 and 08:30 on day 5, all rats were killed by decapitation. Uteri were excised from above the cervices and trimmed of adherent tissues. The horns were separated, slit longitudinally and placed in Hank's balanced salt solution without calcium and magnesium (HBSS; GIBCO, Grand Island, NY). Endometrial stromal cells were iso¬ lated from the uteri by enzymatic digestion by a modification of the methods described by McCormack & Glasser (1980) and Yee & Kennedy (1991 Decidualization /// vivo Rats were killed 5 days after the insertion of pumps and the uterine horns were excised, trimmed of adhering fat and blotted on filter paper. The extent of uterine decidualization was assessed by weighing the infused and non-infused horns separately (Finn & Keen, 1963; Yochim & DeFeo, 1963) .
Endometrial vascular permeability
Changes in endometrial vascular permeability were measured 10 h after the initiation of the infusions, using 125I-labelled bovine serum albumin (125I-labelled BSA) as described by Kennedy (1979) . Fifteen minutes before autopsy, the rats were given an i.v. injection of 8 106 .m. per 250 g body weight of 125I-labelled BSA in saline. The animals were killed and concentrations of radioactivity in serum and in the infused and noninfused horns determined.
Measurement of alkaline phosphatase activity
For assessment in vivo, rats were killed 2 days after pump insertion; uterine horns were excised, washed in 0-9% NaCl, and slit longitudinally. The endometria were scraped mechanically from the myometria, homogenized in glassteflon homogenizers in 0-25% sucrose, and homogenates were frozen until assayed for alkaline phosphatase activity.
Alkaline phosphatase activity of cultured stromal cell was assessed by removing medium at the end of the culture period and washing cells with Dulbecco's phosphate-buffered saline (GIBCO). Some cells were lysed with 0-25% sodium deoxycholate, pH 8 (Sigma), and frozen at -70°C until assayed for alkaline phosphatase activity. The remaining cultures were frozen at -20°C until assayed for protein content. Alkaline phosphatase activity was measured spectrophotometrically as described by Lowry (1957) , with activities expressed as nmol of the product (p-nitrophenol; pNP) produced in 30 min per pg protein (as assessed by the methods of Lowry et ai, 1951, using BSA as the standard). Enalaprilat, angiotensin II, PGE2 and indomethacin did not interfere with alkaline phosphatase determination when added directly to assay tubes.
Measurement of PG concentrations
The radioimmunoassays used to determine the concentrations of PGs of the E and F series are described in Kennedy (1979 Kennedy ( , 1980b . For measurements of PG concentration in uterine homogenates, rats were decapitated 3 h after pump insertion, and the uteri were removed and placed in ice-cold 0-9% saline containing 20 pg indomethacin mC to block further PG synthesis. (Snedecor & Cochrane, 1967) . The significance of treatment effects was determined by mixed-model analysis of variance (Snedecor & Cochrane, 1967) . the variance being partitioned on a within-animal and between-animal basis. Duncan's new multiple range test (Steele & Torrie, 1960) There was no significant difference between groups treated with the angiotensin-converting enzyme inhibitor enalaprilat and control groups in the weights of noninfused uterine horns in this or any subsequent experiment (Fig. 1) . Infusion of the vehicle containing mannitol (25-1 mg ml-1) but no enalaprilat induced an 11-fold increase in the weight of infused uterine horns compared with the noninfused uterine horns. Analysis of variance indicated a significant (P < 0001) dosedependent inhibitory effect of enalaprilat on the weights of the infused uterine horns, interpreted as an inhibitory effect on the decidual cell reaction. Duncan's new multiple range test demonstrated that the weights of uterine horns infused with enalaprilat at 2-5 or 25 pg h_1 were significantly lower than the weights of vehicle plus mannitol-infused uterine horns (P < 005), whereas the lower rates of infusion had no significant effect. By contrast, infusion of enalapril did not inhibit decidualiz¬ ation (P > 005); infusion of enalapril at rates of 0, 0-3, 3 and 30 pg h~' resulted in uterine weights of 1238 +149, 1090 + 216, 1043+141 and 859 ± 132 mg (mean + sem), respectively. Since 25 pg h_1 enalaprilat produced more inhibition (P < 001) than did the 2-5 pgh~' (P < 001), the former was used in subsequent experiments.
Effects of concurrent infusion of angiotensin II or PGE2 with enalaprilat on the decidual cell reaction Angiotensin II infusion at 2 pg h_l (Table 1) or at 0-2 pg h_1 (Table 2) failed to reverse the effect of enalaprilat on the weights of infused uterine horns; angiotensin III infusion at a rate of 2 pg h"1 was also ineffective (Table 2 ). However, infusion of PGE2 caused a significant reversal (P < 001) of the inhibitory response to enalaprilat (Table 1) , although it did not fully restore uterine weights to those of uteri infused with vehicle. The dose of PGE2 used was that shown to override fully the inhibition of the decidual cell reaction produced by indomethacin (Kennedy & Lukash, 1982) . PGF2a (1 pg acid equivalents h_1) did not reverse the effect of enalaprilat, nor did addition of PGF2u to the infusion of enalaprilat plus PGE2 produce uterine weights that were statistically different from those produced by enalaprilat plus PGE2 only ( Changes in endometrial vascular permeability were assessed, using ' 25I-labelled-BSA, 10 h after the implantation of the pumps. Animals receiving vehicle infusions showed significantly greater (P < 001) retention of radioactivity in infused horns than in noninfused horns, and this response was reduced approximately 70% by infusion of enalaprilat (P < 0-01; Table 1 ). Again, concurrent infusion of angiotensin II (2 pg h~' ) did not reverse the inhibition by enalaprilat; concentrations of radioactivity in the group treated with PGE2 were also not statistically different from those in the group treated only with enalaprilat.
Effect of enalaprilat infusion on uterine PG levels There were no significant differences between treatment groups in the concentrations of either PG in noninfused horns, but infusion of the vehicle induced large increases in the concentrations of both PGE and PGF2a in infused uterine horns (P < 0001), and this response was reduced by approximately 80% (P < 001) by infusion of enalaprilat.
Effect of enalaprilat and angiotensin II on stromal cell alkaline phosphatase activity There was no significant effect of enalaprilat on alkaline phosphatase activity of the stromal cells after 24h in culture, but analysis of variance revealed a significant ( < 0001) dosedependent inhibitory effect of enalaprilat, in doses ranging from 10~7 to 10~5 mol 1_1, on alkaline phosphatase activity after 72 h of culture. Analysis of variance also indicated that this effect was significantly reversed by angiotensin II (P < 0001) at doses ranging from 01 to 10 pg ml-1 and revealed a significant (P < 001) interaction between enalaprilat treatment and angiotensin II Fig. 1 Reversal of enalaprilat-induced inhibition of alkaline phosphatase activity by I'( I '., The inhibitory effect of enalaprilat on alkaline phosphatase activity was fully reversed by PGE2 (P < 0001), suggesting that the mechanism of enalaprilat-induced inhibition of alkaline phosphatase activity involves the inhibition of PGE synthesis by the cultured stromal cells (Fig. 3a) .
Effect of angiotensin II on alkaline phosphatase activity in the presence of indomethacin Cells were cultured in the presence of enalaprilat ( 10 "5 mol 1_ ' ), with or without indomethacin (10~5 mol 1_1), an inhibitor of prostaglandin synthetase (Fig. 3b) to test whether the ability of angiotensin II to reverse the inhibition of stromal cell alkaline phosphatase by enalaprilat depends on PG synthesis. The significant (P < 0001) inhibitory effect of enalaprilat on stromal alkaline phosphatase activity was not altered by the presence of indomethacin in the cultures; angiotensin II (10pg ml-1) failed to reverse this inhibition in cells treated with enalaprilat plus indomethacin, suggesting that the ability of angiotensin II to override the inhibition in cultures treated with enalaprilat only depends on stimulation of stromal PG synthesis. ' and angio¬ tensin II on (a) stromal alkaline phosphatase activity measured after 72 h of culture and (b) concentrations of prostaglandin E in media exposed to stromal cells on the third day of culture. Each point represents the mean + sem of the data from four culture wells. functional role for this system in the endometrium has not been elucidated. Our results demonstrate that a specific inhibitor of angiotensin-converting enzyme inhibits the increases in uterine PG concentration, endometrial vascular permeability, endometrial alkaline phosphatase activity and uterine weight that occur sequentially after the application of an intrauterine stimulus for decidualization. The inability of enalapril, administered intraluminally, to produce this effect is consistent with the fact that this product must be metabolized by the liver to enalaprilat (Oparil, 1983) to inhibit angiotensin-converting enzyme; its lack of effect provides evidence that enalaprilat acts specifically on this enzyme. These data suggest that production of angiotensin by the endometrium is necessary for maximal decidualization in rats.
There are several possible explanations for the failure of angiotensin II (and angiotensin III) to override the effects of intraluminally administered converting enzyme inhibitor. Gutman & MazurRuder (1976) have demonstrated a maximum rate of production of angiotensin by rat uterus in vitro of approximately 0-7 pg h" ' per uterus, suggesting that the doses of angiotensin peptides used in our experiments were not too small to be effective. The partial reversal of this inhibition by PGE2 suggests that the effect is not due to a nonspecific toxic action of enalaprilat. It is possible that the effect of enalaprilat is not due to blockade of angiotensin II synthesis but to the accumulation of other angiotensin-converting enzyme substrates. This enzyme is responsible for, in addition to angiotensin II formation, the hydrolysis of both bradykinin (Dorer et al, 1974 ) and substance (Cascieri et al, 1974) . However, no data are available for a role for substance in the decidual cell reaction, and DeFeo (1963) has shown that intraluminal injection of bradykinin stimulates deciduoma formation, so it is unlikely that the accumulation of bradykinin resulting from inhibition of angiotensin-converting enzyme would block decidualization.
The most likely explanation is that the intraluminally infused angiotensin II is restricted to the lumen by the endometrial epithelial cells. These cells have been shown to form a permeability barrier between the lumen and the stroma, and significantly to restrict polar non-electrolytes as small as sucrose on the basis of molecular size (McRae & Kennedy, 1983) . Angiotensin II (Mr = 1046), a peptide, would be retained in the lumen whereas enalaprilat and PGE2, which are smaller, more lipophilic compounds, could more easily diffuse into the uterine tissue. This rationale is supported by our observation that the inhibitory effect of enalaprilat on the increase in alkaline phosphatase activity of cultured endometrial stromal cells, an indicator of the decidual cell reaction in vitro (Daniel & Kennedy, 1987) , can be reversed by angiotensin II. Isolation and culture of individual types of uterine cell have demonstrated that stromal cells from appropriately sensitized animals undergo spontaneous decidualization in vitro as assessed by development of binucleation and other morphological changes (Vladimirsky et al, 1977; Sananes et al, 1978) , and by accumulation of decidual-cell-specific intermediate filaments (Glasser & Julian, 1986; Glasser et al, 1987) . This process is specific for stromal cells from animals exposed to progesterone, since cells from untreated ovariectomized animals did not exhibit this transformation (Sananes et al, 1978) . This model permits the investigation of factors involved in the regulation of stromal cell differentiation in culture. The increase in endometrial stromal alkaline phosphatase activity that accompanies decidualization in vivo can also be observed in cultured endometrial stromal cells undergoing decidualization in vitro (Daniel & Kennedy, 1987) . This increase in alkaline phosphatase is maximal 24-72 h after the induction of decidualization both in vivo and in culture (Yee & Kennedy, 1991) , and is stimulated by PGE2 and inhibited by indomethacin both in vivo (Yee & Kennedy, 1988) , as assessed histochemically and biochemically, and in vitro (Daniel & Kennedy, 1987) Since enalaprilat reduces and angiotensin II restores PGE concentrations in stromal-cellconditioned medium, it appears that the action of angiotensin II on these cells involves stimulation of stromal prostaglandin synthesis. This observation is supported by the ability of PGE2 to reverse fully the inhibitory effect of enalaprilat on stromal alkaline phosphatase activity in the absence of angiotensin II, in contrast with its ability to reverse only partially the inhibitory effect of enalaprilat on decidualization in vivo. The fact that there was an interaction between enalaprilat and angio¬ tensin II for stimulation of alkaline phosphatase activity (i.e. angiotensin II stimulated alkaline phosphatase activity in the presence of enalaprilat but not in its absence) but no interaction between these two treatments for PGE concentrations in media (i.e. angiotensin II increased PGE concentrations even in the absence of enalaprilat) suggests that alkaline phosphatase activity in cultures not treated with enalaprilat was maximally stimulated, such that further increases in media PGE concentration induced by angiotensin II would have no effect on alkaline phosphatase. The failure of angiotensin II to reverse the inhibition of stromal alkaline phosphatase by enalaprilat in the presence of indomethacin indicates that the effect of angiotensin II on cultured stromal cell alkaline phosphatase activity is wholly prostaglandin-dependent; the effect of PGE2 on enalaprilatinduced inhibition of decidualization in vivo suggests that a PG-independent mechanism is also involved. Since the dose and method of administration of PGE2 used was sufficient to reverse fully the inhibition of decidualization resulting from intrauterine infusion of indomethacin (Kennedy & Lukash, 1982) , it is unlikely that limited access of PGE2 to the site of action or rapid breakdown of PGE2 in vivo are responsible for the lack of full effectiveness of this substance in vivo. As PGE2 did not reverse the inhibitory effect of enalaprilat on endometrial vascular permeability, it can be postulated that the suggested PG-independent mechanism may operate at an earlier stage of decidualization than the PG-dependent mechanism.
The stimulation of PG production by angiotensin in cultured endometrial stromal cells is consistent with the effects of angiotensin II in vascular tissue (Robertson & Khairallah, 1972; Gimbrone & Alexander, 1975) and adrenal glomerulosa (Campbell et al, 1979) . The effects of angiotensin on permeability in various vascular beds appear to involve the local production of prostaglandins such as PGE (Robertson & Khairallah, 1972; Gimbrone & Alexander, 1975) . In addition, the mediation of angiotensin-II-induced increases in uterine blood flow by PGE2 in monkeys supports the hypothesis that a proposed role for angiotensin II in the decidual cell reaction may involve PG synthesis, as suggested by the partial reversal of the inhibitory effect of enalaprilat on uterine weight by co-infusion of PGE2, and by enalaprilat-induced reduction of uterine PG concentrations. The present experiments, however, do not distinguish between angio¬ tensin II and III, the latter being a more potent stimulator of PG release in other tissues (Blumberg et al, 1976) .
In summary, these experiments suggest a requirement for angiotensin-converting enzyme activity and angiotensin II production for maximal expression of the decidual cell reaction in rats. The proposed role of angiotensin II in decidualization appears to involve endometrial synthesis of PGs, as well as a mechanism of action that may be independent of PGs. In identified angiotensin target tissues, the interaction of angiotensin II with its receptor is thought to involve increases in intracellular calcium concentration, phosphoinositide turnover and diacylglycerol production with accompanying activation of protein kinase C (Goodfriend, 1983; Griendling et al, 1988) . Studies are currently under way to determine whether a calcium-dependent mechanism accounts for the discrepancy between the ability of PGE2 to reverse inhibition by angiotensin-converting enzyme of decidualization in vivo and in vitro.
